CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-16 | Beyer Pat Director | Option exercise | +965 | 965 | ||
| 2022-06-16 | Beyer Pat Director | Option exercise · Restricted Stock Units | −965 | 1,930 | ||
| 2022-06-16 | McMurry-Heath Michelle Director | Option exercise | +385 | 385 | ||
| 2022-06-16 | McMurry-Heath Michelle Director | Option exercise · Restricted Stock Units | −385 | 772 | ||
| 2022-06-16 | Ladone Mary Kay Director | Option exercise | +1,813 | 1,813 | ||
| 2022-06-16 | Ladone Mary Kay Director | Option exercise · Restricted Stock Units | −1,813 | 3,627 | ||
| 2022-04-04 | D'Adamio Anthony SVP & General Counsel | Sale | −16,016 | $11.19 | $179K | 40,132 |
| 2022-04-04 | Nosenzo John Chief Commercial Officer | Sale | −65,963 | $11.12 | $734K | 83,932 |
| 2022-04-04 | Pavesio Alessandra SVP & Chief Science Officer | Sale | −32,997 | $11.17 | $368K | 148,309 |
| 2022-04-04 | Singleton Mark Leonard SVP & CFO | Grant or award · Restricted Stock Units | +74,500 | 74,500 | ||
| 2022-04-04 | Singleton Mark Leonard SVP & CFO | Grant or award · Stock Option (Right to Buy) | +223,200 | 223,200 | ||
| 2022-04-01 | CHURCH KATRINA J SVP & Chief Compliance Officer | Sale | −15 | $14.07 | $211 | 10,338 |
| 2022-04-01 | Nosenzo John Fmr. Chief Commercial Officer | Sale 10b5-1 | −40 | $14.07 | $563 | 87,250 |
| 2022-04-01 | CHURCH KATRINA J SVP & Chief Compliance Officer | Sale 10b5-1 | −15 | $14.07 | $211 | 10,338 |
| 2022-04-01 | HAWKINS WILLIAM A Director | Option exercise | +40,573 | 92,361 | ||
| 2022-04-01 | HAWKINS WILLIAM A Director | Option exercise · Restricted Stock Units | −40,573 | 0 | ||
| 2022-04-01 | D'Adamio Anthony SVP & General Counsel | Option exercise | +37,476 | 56,148 | ||
| 2022-04-01 | D'Adamio Anthony SVP & General Counsel | Option exercise · Restricted Stock Units | −37,476 | 0 | ||
| 2022-04-01 | Nosenzo John Chief Commercial Officer | Option exercise | +106,485 | 149,895 | ||
| 2022-04-01 | Nosenzo John Chief Commercial Officer | Option exercise · Restricted Stock Units | −106,485 | 0 |
Page 18 of 22 · 437 trades